-
Business 
Biologics accounted for 27% of total revenue in FY19biologics Biocon post double-digit growth in both revenue and net profit over the next three financial years.
Biologics accounted for 27% of total revenue in FY19biologics Biocon post double-digit growth in both revenue and net profit over the next three financial years.